Paul Hudson
About Paul Hudson
Paul Hudson is the Chief Executive Officer of Sanofi, known for his leadership in transforming the company's portfolio and celebrating significant achievements in the healthcare sector.
Paul Hudson Chief Executive Officer
Paul Hudson has held the position of Chief Executive Officer at Sanofi since September 2019. Prior to this role, he served as the Chief Executive Officer of Novartis Pharmaceuticals from 2016 to 2019. As CEO, Hudson oversees the strategic direction of the company, driving innovation across its portfolio of medicines and vaccines.
Presentation at J.P. Morgan Healthcare Conference 2024
Paul Hudson presented at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on January 9th, 2024. This conference is a significant event in the healthcare industry, attracting global leaders to discuss developments and future strategies.
Sanofi Q1 2024 Financial Results Commentary
In Q1 2024, Paul Hudson highlighted the transformation of Sanofi's portfolio of medicines and vaccines. His comments reflected the company's strategic shifts and commitments to innovate within the pharmaceutical landscape, marking advancements in their product offerings.
Sanofi Q2 2024 Financial Results Commentary
Paul Hudson commented on the Q2 2024 results, emphasizing Sanofi's strong performance and significant progress in their pipeline of new medicines. Hudson's insights underscored the continuous efforts to bring innovative treatments to market.
Approval of Dupixent for COPD in the EU
Under Paul Hudson's leadership, Sanofi achieved the milestone of having Dupixent approved for COPD in the EU, making it the first-ever biologic treatment for this condition. This approval represents a significant breakthrough in respiratory treatments.
Ezra Frech's Gold Medal Celebration
In July 2023, Paul Hudson celebrated Ezra Frech's gold medal at the World Para-Athletics Championship in Paris. This event highlighted Sanofi's support and recognition of achievements in the para-athletic community.